Key result
High hospital MCS utilization shows no mortality benefit over low utilization in cardiogenic shock.
Why the study?
Limited knowledge exists on inter-hospital variation in the utilization of short-term nondurable mechanical circulatory support for myocardial infarction complicated by cardiogenic shock.
Does higher hospital utilization of short-term nondurable mechanical circulatory support reduce in-hospital mortality in patients with myocardial infarction complicated by cardiogenic shock?
Observational
Yes
Does higher hospital utilization of short-term nondurable mechanical circulatory support reduce in-hospital mortality in patients with myocardial infarction complicated by cardiogenic shock?
There is wide inter-hospital variation in the use of short-term mechanical circulatory support for MI complicated by cardiogenic shock, but higher utilization is not associated with improved risk-adjusted in-hospital mortality.
Answers are grounded in this paper and cite their sources.
Wide interhospital MCS variation for MI-CS without mortality difference warrants standardization; leaves open optimal device selection in observational data.
BACKGROUND: Limited knowledge exists on inter-hospital variation in the utilization of short-term, nondurable mechanical circulatory support (MCS) for myocardial infarction (MI) complicated by cardiogenic shock (CS). METHODS AND RESULTS: Hospitalizations for MI with CS in 2014 in a nationally representative all-payer database were included. The proportion of hospitalizations for MI with CS using MCS (MCS ratio) and in-hospital mortality were evaluated. Hospital characteristics and outcomes were compared across quartiles of MCS usage. Of 1813 hospitals evaluated, 1440 (79.4%) performed ≥10 percutaneous coronary interventions annually. Of these, 1064 (73.9%) had at least one code for MCS. Forty-one percent of hospitals did not use MCS. The median (interquartile range) proportion of MCS use among admissions for MI with CS was 33.3% (0.0%-50.0%). High MCS utilizing hospitals were larger ( P<0.001). Eighty-five percent (2808/3301) of MCS use was intra-aortic balloon pump. There was significant variation in receipt of MCS at different hospitals (median odds ratio of receiving MCS at 2 random hospitals: 1.58; 95% CI, 1.45-1.70). Adjusted in-hospital mortality was not different across quartiles of MCS use (Q4 versus Q1; odds ratio, 0.95; 95% CI, 0.77-1.16; P=0.58). CONCLUSIONS: Wide variation exists in hospital use of MCS for MI with CS, unexplained by patient characteristics. The predominant form of MCS use is intra-aortic balloon pump. Risk-adjusted mortality rates were not different between higher and lower MCS-utilizing hospitals.
No takes yet. Share an insight, caveat, or question.
Strom et al. (2019) conducted an observational in Myocardial infarction complicated by cardiogenic shock. High hospital utilization of mechanical circulatory support (MCS) vs. Low hospital utilization of MCS (Q1) was evaluated on Adjusted in-hospital mortality (OR 0.95, 95% CI 0.77-1.16, p=0.58). High hospital utilization of mechanical circulatory support for MI with cardiogenic shock was not associated with a difference in adjusted in-hospital mortality compared to low utilization.
Synapse has enriched 10 related papers. Consider them for comparative context: